Conduit Pharmaceuticals Inc. (NASDAQ:CDTTW) Sees Large Drop in Short Interest

Conduit Pharmaceuticals Inc. (NASDAQ:CDTTW) was the recipient of a significant decrease in short interest during the month of January. As of January 15th, there was short interest totalling 29,500 shares, a decrease of 80.9% from the December 31st total of 154,100 shares. Based on an average daily trading volume, of 101,700 shares, the days-to-cover ratio is currently 0.3 days.

Conduit Pharmaceuticals Price Performance

Shares of CDTTW stock traded up $0.00 during mid-day trading on Thursday, hitting $0.01. The stock had a trading volume of 752 shares, compared to its average volume of 322,731. The firm’s 50-day moving average is $0.01 and its two-hundred day moving average is $0.01. Conduit Pharmaceuticals has a 12-month low of $0.01 and a 12-month high of $0.15.

About Conduit Pharmaceuticals

Conduit Pharmaceuticals Inc, a clinical-stage specialty biopharmaceutical company, develops pharmaceutical products that provides unmet medical needs in the areas of autoimmune diseases and idiopathic male infertility. Its pipeline includes AZD1656, which has completed Phase I trials for the treatment of type 2 diabetes, renal transplant, Hashimoto's thyroiditis and Grave's disease, uveitis, and preterm labor; and AZD5904, which has completed Phase I clinical trials for the treatment of idiopathic male infertility.